Pills, patches, rings and injectables
- Method or treatment
Pills, patches, rings and injections all use the body's own signals to stop ovulation. The key question is whether the method contains oestrogen.
See it in 3D: Ovaries · Cervix · Body of uterus
What it is
Short-acting hormonal methods are combined methods, containing an oestrogen (usually ethinylestradiol) and a progestogen, given as a daily pill, weekly patch, monthly vaginal ring or monthly injection, and progestogen-only methods: the progestogen-only pill and the injectable given every three months (medroxyprogesterone acetate). Combined methods suppress the mid-cycle LH surge so ovulation does not happen; progestogens also thicken cervical mucus. With typical use about 7 in 100 women using the pill, patch or ring and about 4 using the injectable become pregnant each year, mostly from missed or late doses.
How it works and how well
- Combined methods act centrally: oestrogen and progestogen feed back on the hypothalamus and pituitary, suppressing FSH and the LH surge, so no follicle ovulates.
- The pill, patch and ring share the same contraindications; the patch gives slightly higher oestrogen exposure.
- The danger time for missed pills is around the hormone-free interval: extending it lets a follicle grow and ovulate.
- The three-monthly injectable lowers bone density while used (mostly reversible) and fertility may take months to return after stopping.
- Combined methods reduce the risk of ovarian and endometrial cancer, heavy and painful periods, and acne.
Combined or progestogen-only?
| Feature | Combined (pill, patch, ring, monthly injection) | Progestogen-only pill | Three-monthly injectable |
|---|---|---|---|
| Mechanism | Stops ovulation | Thickens mucus; some types stop ovulation | Stops ovulation |
| User action | Daily, weekly or monthly | Daily, on time | An injection every three months |
| Bleeding | Regular, lighter withdrawal bleeds | Irregular | Irregular, then often absent |
| Thrombosis risk | Increased | Not meaningfully increased | Small increase is debated |
| Main cautions | Smoker 35+, migraine with aura, past VTE, uncontrolled hypertension, early postpartum | Current breast cancer | Bone density, delayed return of fertility, weight gain in some |
| Breastfeeding | Avoid in the first weeks; later with caution | Suitable | Suitable |
Risks and who should not use it
- Clot chain: oestrogen → liver makes more clotting factors and less natural anticoagulant → hypercoagulable state → venous thrombosis risk rises, highest in the first months of use; still lower than in pregnancy and after birth.
- Smoking plus oestrogen over 35 → added arterial risk → myocardial infarction and stroke: combined methods are not used.
- Migraine with aura plus oestrogen → raised ischaemic stroke risk: combined methods are not used at any age.
- Enzyme inducers (rifampicin, carbamazepine, phenytoin, some antiretrovirals) lower hormone levels: choose an IUD or injectable.
- Severe vomiting or diarrhoea may reduce absorption of pills; follow missed-pill guidance.
Next step / Follow-up
- Before starting: exclude pregnancy with reasonable certainty, measure blood pressure for combined methods, and screen the history for WHO MEC contraindications; no pelvic exam, cytology or blood tests are needed.
- Quick start: begin on any day if pregnancy is reasonably excluded, with backup contraception for the first days unless started early in the cycle.
- Review blood pressure and side effects after the first months, then yearly; switch method if bleeding or other effects are not tolerated.
- Stop combined methods and assess urgently for calf swelling, chest pain, breathlessness, new focal neurological symptoms or migraine with aura.
- Offer LARC as an alternative whenever adherence is a problem.
Common traps
- The pill causes breast and cervical cancer, so it is dangerous: the small rise in breast cancer risk while used fades after stopping, and it lowers ovarian and endometrial cancer risk substantially.
- All antibiotics stop the pill: only enzyme inducers such as rifampicin do; ordinary antibiotics like amoxicillin do not.
- The injectable's bone loss means it must be stopped after two years: the loss is largely reversible, and benefits usually outweigh it; discuss and reassess rather than stop automatically.
- Missing a pill in the middle of the pack is the most dangerous: the riskiest missed pills are those that lengthen the hormone-free interval, at the start or end of the pack.
Test yourself
Think of the answer, then tap the question to see it.
A 30-year-old with migraine with aura asks for the combined pill. What do you advise and why?
Combined methods are not used: oestrogen with migraine aura raises the risk of ischaemic stroke. Offer a progestogen-only method, an implant or an IUD.
Why is the patch less forgiving than a well-used implant?
The patch depends on the user changing it each week and keeping it attached, whereas the implant needs no action; typical-use failure is much higher for the patch.
A woman stopped the three-monthly injectable to conceive and has not ovulated after four months. Is this abnormal?
Not necessarily: return of fertility after this injectable can take several months; she can be reassured and reviewed later.
Elsewhere in DurgiPedia
- Contraception counselling: the methods, eligibility in general terms, LARC and after birth or abortion
- Contraception: how each method prevents fertilization or implantation
- The menstrual cycle: ovary and endometrium
Connections
See it in 3D3
The structures of Durgical's 3D anatomy where it is found.
← All of obstetrics and gynaecology
Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.
Sources: Oral Contraceptive Pills (StatPearls (NCBI Bookshelf), 2024); Medroxyprogesterone (StatPearls (NCBI Bookshelf), 2024); Medical eligibility criteria for contraceptive use, 6th ed. (World Health Organization, 2025); About contraception: methods and effectiveness (Centers for Disease Control and Prevention, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
